Korean Drug Co Ltd - ESG Rating & Company Profile powered by AI
Detailed ESG analysis of Korean Drug Co Ltd are reached by logging in. The analysis of Korean Drug Co Ltd was prepared by All Street Sevva using leading NLP. If you are employed by Korean Drug Co Ltd and you wish to licence your ESG rating, please get in touch.
Korean Drug Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Korean Drug Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Korean Drug Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Korean Drug Co Ltd disclose current and historical energy intensity?
Does Korean Drug Co Ltd report the average age of the workforce?
Does Korean Drug Co Ltd reference operational or capital allocation in relation to climate change?
Does Korean Drug Co Ltd disclose its ethnicity pay gap?
Does Korean Drug Co Ltd disclose cybersecurity risks?
Does Korean Drug Co Ltd offer flexible work?
Does Korean Drug Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Korean Drug Co Ltd disclose the number of employees in R&D functions?
Does Korean Drug Co Ltd conduct supply chain audits?
Does Korean Drug Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Korean Drug Co Ltd conduct 360 degree staff reviews?
Does Korean Drug Co Ltd disclose the individual responsible for D&I?
Does Korean Drug Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Korean Drug Co Ltd disclose current and / or historical scope 2 emissions?
Does Korean Drug Co Ltd disclose water use targets?
Does Korean Drug Co Ltd have careers partnerships with academic institutions?
Did Korean Drug Co Ltd have a product recall in the last two years?
Does Korean Drug Co Ltd disclose incidents of discrimination?
Does Korean Drug Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Korean Drug Co Ltd issued a profit warning in the past 24 months?
Does Korean Drug Co Ltd disclose parental leave metrics?
Does Korean Drug Co Ltd disclose climate scenario or pathway analysis?
Does Korean Drug Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Korean Drug Co Ltd disclose the pay ratio of women to men?
Does Korean Drug Co Ltd support suppliers with sustainability related research and development?
Does Korean Drug Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Korean Drug Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Korean Drug Co Ltd involved in embryonic stem cell research?
Does Korean Drug Co Ltd disclose GHG and Air Emissions intensity?
Does Korean Drug Co Ltd disclose its waste policy?
Does Korean Drug Co Ltd report according to TCFD requirements?
Does Korean Drug Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Korean Drug Co Ltd disclose energy use targets?
Does Korean Drug Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Korean Drug Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Korean Drug Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Korean Drug Co., Ltd. develops, manufactures, and sales medicines for treating various diseases in South Korea. The company provides medicines for treating central nervous system and cold. It also offers prescription drugs, including antibiotic, antifungal, digestive system medicine, circulatory system, psychiatric, and central nervous system drugs; drugs for the urinary system, and skinantiviral. In addition, the company provides over the counter drugs comprising drugs for liver disease and cold medicine, as well as offers health functional foods. Further, the company offers xprugel, a transparent gel for disinfection of hands and skin. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.